Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Ark buying these names is more a sentiment signal than a fundamental seal of approval. The common thread is optionality: each business is trying to convert scale into operating leverage, but the market will quickly distinguish between genuine margin inflection and temporary narrative support from retail/influencer flows. In that context, Shopify is the cleanest quality compounder because software-like mix shift can keep pushing FCF margin up even if GMV growth normalizes; Amazon/BigCommerce merchants are the real competitive benchmark, not other “growth” names.

DraftKings is the most vulnerable to second-order pricing pressure. If one major competitor refuses surcharges, the whole industry’s ability to defend promo intensity is weaker than management teams want investors to believe, which compresses long-run take rates even if top-line units keep rising. Tempus sits in a different bucket: it is less about near-term earnings and more about whether the workflow/data moat can become a reimbursement-supported standard of care; the stock can rerate hard on every clinical/partnering headline, but that also makes it fragile if adoption or gross margin quality disappoints. Over 1-3 months, Ark accumulation can support these names mechanically; over 6-18 months, only unit economics will matter.